{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:26:05Z","timestamp":1772241965369,"version":"3.50.1"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.2169\/internalmedicine.7886-21","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:14:34Z","timestamp":1648764874000},"page":"969-977","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Impact of Circulating Galectin-3 on Ventricular Arrhythmias and Heart Failure Hospitalization Independent of Prior Ventricular Arrhythmic Events in Patients with Implantable Cardioverter-defibrillators"],"prefix":"10.2169","volume":"61","author":[{"given":"Hisaki","family":"Makimoto","sequence":"first","affiliation":[{"name":"Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, Germany"},{"name":"CARID, Cardiovascular Research Institute D\u00fcsseldorf, Medical Faculty, Heinrich-Heine-University, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kullmann","family":"Denise","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Clasen","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Lin","sequence":"additional","affiliation":[{"name":"GenesisCare, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Angendohr","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Brinkmeyer","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, Germany"},{"name":"CARID, Cardiovascular Research Institute D\u00fcsseldorf, Medical Faculty, Heinrich-Heine-University, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Bejinariu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36: 2793-2867, 2015.","DOI":"10.1093\/eurheartj\/ehv316"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gulati A, Japp AG, Raza S, et al. Absence of myocardial fibrosis predicts favorable long-term survival in new-onset heart failure. Circ Cardiovasc Imaging 11: e007722, 2018.","DOI":"10.1161\/CIRCIMAGING.118.007722"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309: 896-908, 2013.","DOI":"10.1001\/jama.2013.1363"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Francia P, Adduci C, Semprini L, et al. Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators. J Cardiovasc Electrophysiol 25: 609-616, 2014.","DOI":"10.1111\/jce.12364"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ueland T, Aukrust P, Broch K, et al. Galectin-3 in heart failure: high levels are associated with all-cause mortality. Int J Cardiol 150: 361-364, 2011.","DOI":"10.1016\/j.ijcard.2011.05.081"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lok DJ, Van Der Meer P, de la Porte PW, et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 99: 323-328, 2010.","DOI":"10.1007\/s00392-010-0125-y"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tang WH, Shrestha K, Shao Z, et al. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. Am J Cardiol 108: 385-390, 2011.","DOI":"10.1016\/j.amjcard.2011.03.056"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 70: 776-803, 2017.","DOI":"10.1161\/CIR.0000000000000509"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zile MR, O&apos;Meara E, Claggett B, et al. Effects of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF. J Am Coll Cardiol 73: 795-806, 2019.","DOI":"10.1016\/j.jacc.2018.11.042"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Felker GM, Fiuzat M, Shaw LK, et al. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study. Circ Heart Fail 5: 72-78, 2012.","DOI":"10.1161\/CIRCHEARTFAILURE.111.963637"},{"key":"11","unstructured":"11. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 138: e272-e391, 2018."},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Wilkoff BL, Fauchier L, Stiles MK, et al.; Document Reviewers. 2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace 18: 159-183, 2016.","DOI":"10.1093\/europace\/euv411"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gullestad L, Ueland T, Kjekshus J, et al. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Am Heart J 164: 878-883, 2012.","DOI":"10.1016\/j.ahj.2012.08.021"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. de Boer RA, Lok DJ, Jaarsma T, et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 43: 60-68, 2011.","DOI":"10.3109\/07853890.2010.538080"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Makimoto H, Zielke S, Clasen L, et al. Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients. Eur J Med Res 25: 5, 2020.","DOI":"10.1186\/s40001-020-0401-x"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Sharma UC, Pokharel S, van Brakel TJ, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110: 3121-3128, 2004.","DOI":"10.1161\/01.CIR.0000147181.65298.4D"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Vergaro G, Del Franco A, Giannoni A, et al. Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy. Int J Cardiol 184: 96-100, 2015.","DOI":"10.1016\/j.ijcard.2015.02.008"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. de Boer RA, Voors AA, Muntendam P, van Gilst WH, van Veldhuisen DJ. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail 11: 811-817, 2009.","DOI":"10.1093\/eurjhf\/hfp097"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chery G, Kamp N, Kosinski AS, et al. Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: systematic review. Am Heart J 229: 52-60, 2020.","DOI":"10.1016\/j.ahj.2020.08.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zegard A, Okafor O, de Bono J, et al. Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease. J Am Coll Cardiol 77: 29-41, 2021.","DOI":"10.1016\/j.jacc.2020.10.046"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/7\/61_7886-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:11:21Z","timestamp":1715231481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/7\/61_7886-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7886-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"article-number":"7886-21"}}